Hyperkalemia was more common among older women treated with spironolactone for a skin condition, and among those with comorbidities, but cases were usually mild and rarely altered care, a study ...

Postoperative hyperkalemia is an important complication of adrenalectomy for aldosterone-producing adenoma. Recently, postoperative hyperkalemia has been found to have a relatively high incidence ...

LISBON, PORTUGAL — Elevated potassium is common and associated with poor outcomes in a real-world population of patients with diabetes, new research finds. Results from the Danish population-based ...

Dublin, March 19, 2021 (GLOBE NEWSWIRE) -- The "Hyperkalemia - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report ...

Hyperkalemia is a potentially serious condition that can result in life-threatening cardiac arrhythmias and is associated with an increased mortality risk. Patients older than 65 years who have an ...

Although serum potassium monitoring is recommended to reduce the risk of hyperkalemia, only a small percentage of patients taking RAAS inhibitors are monitored. Hyperkalemia diagnosis is often missed ...

G_hyperkalemia_web How much do your patients know about the dangers of high potassium levels in the body? They may know that potassium is good for you, or that you need specific levels of it in the ...

G_hyperkalemia_web Longitudinal study with preplanned serum potassium measurements may provide a more accurate estimate of the burden of hyperkalemia among CKD patients. Nearly one third of patients ...

Please provide your email address to receive an email when new articles are posted on . An analysis of transgender teens prescribed spironolactone showed that only 2.2% developed hyperkalemia after ...

Hyperkalemia is an abnormally high level of potassium in the blood. The normal level of serum potassium (potassium in the fluid portion of the blood) is 3.5 to 5.0 mmol/l. When serum potassium is ...

Amid positive data from three trials on two novel agents for hyperkalemia, questions about long-term safety and efficacy remain, researchers said. According to an editorial in the New England Journal ...